Clinical validity of plasma and urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer

被引:0
|
作者
Abe, Masakazu [1 ]
Hiraki, Hayato [1 ]
Tamura, Daichi [2 ]
Kato, Renpei [3 ]
Maekawa, Shigekatsu [3 ]
Takata, Ryo [3 ]
Obara, Wataru [3 ]
Nishizuka, Satoshi [1 ]
机构
[1] Iwate Med Univ, Div Biomed Res & Dev, Morioka, Iwate, Japan
[2] Iwate Med Univ, Sch Med, Dept Urol, Morioka, Iwate, Japan
[3] Iwate Med Sch Med, Dept Urol, Morioka, Iwate, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3303
引用
收藏
页码:2187 / 2187
页数:1
相关论文
共 50 条
  • [1] The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer
    Abe, Masakazu
    Hiraki, Hayato
    Tsuyukubo, Takashi
    Ono, Sadahide
    Maekawa, Shigekatsu
    Tamura, Daichi
    Yashima-Abo, Akiko
    Kato, Rennpei
    Fujisawa, Hiromitsu
    Iwaya, Takeshi
    Park, Woong-Yang
    Idogawa, Masashi
    Tokino, Takashi
    Obara, Wataru
    Nishizuka, Satoshi S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (04): : 278 - 291
  • [2] The clinical validity of urinary pellet DNA monitoring of recurrent bladder cancer
    Abe, Masakazu
    Hiraki, Hayato
    Tsuyukubo, Takashi
    Ono, Sadahide
    Maekawa, Shigekatsu
    Tamura, Daichi
    Ikarashi, Daiki
    Kato, Renpei
    Matsuura, Tomohiko
    Kanehira, Mitsugu
    Takata, Ryo
    Fujisawa, Hiromitsu
    Iwaya, Takeshi
    Idogawa, Masashi
    Obara, Wataru
    Nishizuka, Satoshi S.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Urinary Markers for Bladder Cancer Diagnosis and Monitoring
    Jeong, Seung-Hwan
    Ku, Ja Hyeon
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [4] Urinary DNA Methylation Test for Bladder Cancer Diagnosis
    Jeong, In Gab
    Yun, Sung-Cheol
    Ha, Hong Koo
    Kang, Sung Gu
    Lee, Sangchul
    Park, Sungchan
    Sung, Hyun Hwan
    Kim, Sun Il
    Hwang, Eu Chang
    Moon, Kyung Cheol
    Kwak, Cheol
    JAMA ONCOLOGY, 2025,
  • [5] Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
    K. M. Patel
    K. E. van der Vos
    C. G. Smith
    F. Mouliere
    D. Tsui
    J. Morris
    D. Chandrananda
    F. Marass
    D. van den Broek
    D. E. Neal
    V. J. Gnanapragasam
    T. Forshew
    B. W. van Rhijn
    C. E. Massie
    N. Rosenfeld
    M. S. van der Heijden
    Scientific Reports, 7
  • [6] Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
    Patel, K. M.
    van der Vos, K. E.
    Smith, C. G.
    Mouliere, F.
    Tsui, D.
    Morris, J.
    Chandrananda, D.
    Marass, F.
    van den Broek, D.
    Neal, D. E.
    Gnanapragasam, V. J.
    Forshew, T.
    van Rhijn, B. W.
    Massie, C. E.
    Rosenfeld, N.
    van der Heijden, M. S.
    SCIENTIFIC REPORTS, 2017, 7
  • [7] CLINICAL-DIAGNOSIS OF URINARY-BLADDER CANCER
    RUBBEN, H
    DAHM, HH
    LUTZEYER, W
    ONKOLOGIE, 1980, 3 (05): : 225 - 232
  • [8] Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring
    Zeng, Yuchen
    Wang, Anqi
    Lv, Wei
    Wang, Qingqing
    Jiang, Shiqi
    Pan, Xiaoguang
    Wang, Fei
    Yang, Huanming
    Bolund, Lars
    Lin, Chunhua
    Han, Peng
    Luo, Yonglun
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (02):
  • [9] ACCURACY OF URINARY CYTOLOGY IN THE DIAGNOSIS OF PRIMARY AND RECURRENT BLADDER-CANCER
    WIENER, HG
    PETERVOOIJS, G
    VANTHOFGROOTENBOER, B
    ACTA CYTOLOGICA, 1993, 37 (02) : 163 - 169
  • [10] Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancer
    Shigehiro Tsukahara
    Masaki Shiota
    Takashi Matsumoto
    Dai Takamatsu
    Shohei Nagakawa
    Nozomi Noda
    Shinya Matsumoto
    Mikako Yagi
    Takeshi Uchiumi
    Yuya Kunisaki
    Dongchon Kang
    Masatoshi Eto
    BJC Reports, 3 (1):